Business
PureTech to Present at the JP Morgan Conference
PureTech Health plc announced that its Chief Executive Officer will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, at 4:30pm PST. A webcast of the presentation will be available on the company's investor relations website. The company, a biotherapeutics firm, aims to transform innovation into value through a capital-efficient R&D model, having already achieved three U.S. FDA approvals. Disclaimer*
About this update from Puretech Health Plc
[{"type":"text","content":"\n\n6 January 2026\nPureTech Health plc\n \nPureTech to Present at 44th Annual J.P. Morgan Healthcare Conference\n \nPureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (\"PureTech\" or the \"Company\"), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced that Robert Lyne, Chief Executive Officer, will present at the 44th annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 4:30pm PST / 7:30pm EST. A webcast of the presentation will be available at https://investors.puretechhealth.com.\n \nAbout PureTech Health \nPureTech Health is a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value. We do this through a proven, capital-efficient R&D model focused on opportunities with validated pharmacology and untapped potential to address significant patient needs. This strategy has produced dozens of therapeutic candidates, including three that have received U.S. FDA approval. By identifying, shaping, and de-risking these high-conviction assets, and scaling them through dedicated structures backed by external capital, we accelerate their path to patients while creating sustainable value for shareholders.\n \nFor more information, visit www.puretechhealth.com or connect with us on X (formerly Twitter) @puretechh. \n \nCautionary Note Regarding Forward-Looking Statements\nThis press release contains statements that are or may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation those related to our upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference and our future plans, prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks, uncertainties and other important factors that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risks, uncertainties and other important factors described under the caption \"Risk Factors\" in...